Standout Papers
Immediate Impact
1 from Science/Nature 83 standout
Citing Papers
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Jinzhou Wang being referenced
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
2010 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jinzhou Wang | 197 | 162 | 227 | 553 | 404 | 15 | 877 | |
| Jimmy Yuen | 130 | 172 | 228 | 586 | 285 | 12 | 858 | |
| Yasuo Endo | 238 | 143 | 185 | 542 | 347 | 20 | 882 | |
| M. Giovanelli | 141 | 157 | 277 | 531 | 283 | 10 | 796 | |
| Yasuro Niwa | 93 | 151 | 154 | 544 | 378 | 13 | 813 | |
| Chao‐Wei Hsu | 151 | 120 | 139 | 717 | 554 | 25 | 946 | |
| Yasushi Shiratori | 271 | 234 | 165 | 556 | 395 | 18 | 1.1k | |
| Stefania De Notariis | 161 | 120 | 151 | 870 | 741 | 14 | 1.1k | |
| Brian Shrager | 109 | 162 | 336 | 530 | 252 | 11 | 872 | |
| Kai Feng | 82 | 129 | 262 | 644 | 488 | 24 | 902 | |
| Yoshinari Takemoto | 121 | 198 | 417 | 781 | 365 | 19 | 1.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...